Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02983240
Other study ID # IRB201601699 - A
Secondary ID OCR26522E-BIO CO
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2017
Est. completion date January 21, 2023

Study information

Verified date December 2022
Source e-Bio Corp
Contact John Smulian, MD
Phone 352-273-7580
Email jsmulian@ufl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore a new method to stop preterm uterine contractions using an electrical device. The device, an "electrical pacemaker for the uterus," has been approved by the Food and Drug Administration (FDA) for clinical research in pregnant women. The purpose of this study is to evaluate the feasibility and safety of the device. The investigators hypothesize that human preterm uterine contractions can be safely and objectively inhibited with a weak electrical current provided by an electrical inhibition (EI)/uterine pacemaker device, and that this effect relates to the timing and length of EI exposure.


Description:

The purpose of this study is to determine the effectiveness of a new method of preventing the human preterm uterine contractions of labor during electrical monitoring. The objective is to test a method for the inhibition of human preterm uterine contractions with an electrical pacemaker, electrical inhibition (EI). The study will investigate EI associated changes in preterm uterine contraction frequency as monitored by objective uterine tocodynamometry and adjunct electromyography (EMG) and electrohysterogram (EHG). The endpoint is the statistically significant EI induced decrease in the gold standard tocodynamometric monitored preterm uterine contraction frequency. The adjunct EMG and EHG monitoring provides valuable adjunct data about the electrical activity of the preterm uterine contractions and the effect of EI on this activity. The investigators hypothesize that human preterm uterine contractions can be safely and objectively inhibited with a weak electrical current provided by an electrical inhibition (EI)/uterine pacemaker device. This effect can be assessed by the use of a non-invasive tocodynamometer. It has been previously been shown that the frequency of contractions during preterm labor can be lowered by EI applied by the use of an intravaginal catheter carrying electrodes similar to a cardiac pacemaker (Karsdon et al). The investigators hypothesize that this effect relates to the timing and length of EI exposure.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date January 21, 2023
Est. primary completion date January 21, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Wong-Baker pain score = 6 - Pregnancy Depression Scale score < 16 - Informed consent form signed and dated by patient - Be willing and able to comply with study requirements - Be between 18-50 years of age - Be between 23 to 36 5/7 weeks pregnant with a singleton gestation - Cervical dilation of = 6 cm - A normal spontaneous vaginal delivery (NSVD) expected - Suspected to have preterm labor, as defined by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics, as follows.78 - Persistent uterine contractions (4 every 20 minutes, or 8 every 60 minutes) - And any one or more of the following: - Documented cervical change - 1 cm cervical dilatation and progressing -> 80% cervical effacement - Be admitted to the maternity unit with the diagnosis of preterm labor or preterm contractions Exclusion Criteria: - Severe preeclampsia - Severe abruption placenta - Abnormal placentation (i.e. placenta previa) - Rupture of amniotic membranes - Active preterm labor with cervical dilation > 6 cm - Exposed amniotic membranes - Vaginal bleeding > 10 cc - Frank chorioamnionitis - Fetal death - Fetal anomaly incompatible with life - Severe fetal growth restriction (EFW < 5%) - Uterine anomalies (i.e. bicornuate uterus, uterine didelphys) - Mature fetal lung studies - Maternal cardiac arrhythmias - HIV, Hepatitis C, Hepatitis B - History of herpes simplex virus (HSV) - A permanent cardiac pacemaker - A fetal cardiac arrhythmia - Contraindication for tocolysis e.g. premature rupture of the amniotic membranes allowing for ascending intrauterine infection with group B streptococcus or GBS (beta hemolytic streptococcus, S. agalactiae) or other micro-organisms. - IV or po narcotic pain medication < 12 hours prior to admission (regional anesthesia, long acting oral maintenance opiates i.e. methadone, Suboxone, Subutex not included in exclusion criteria)

Study Design


Intervention

Device:
Electrical Uterine Pacemaker
The catheter is placed under ultrasound guidance into the posterior vaginal fornix next to the external cervical os. The electrode connectors are attached to the EI device. Activating the EI device involves: 1) turning the current pulse duration rotary dial clockwise to the desired setting; this is an important setting and should be set at 20ms; 2) turning the current frequency rotary dial clockwise to the desired setting; 3) turn on the EI device on with the on/off toggle switch; 4) SLOWLY turning the current strength rotary dial clockwise to the desired setting, at this time the red light should be flashing. Usually 5-10mA of current is sufficient, but 20 mA is a maximum. Based on the tocometer recordings the least amount of EI current is given to inhibit the uterine contractions.

Locations

Country Name City State
United States University of Florida Gainesville Florida

Sponsors (1)

Lead Sponsor Collaborator
e-Bio Corp

Country where clinical trial is conducted

United States, 

References & Publications (1)

Karsdon J, El Daouk M, Huang WM, Ashmead GG. Electrical pacemaker as a safe and feasible method for decreasing the uterine contractions of human preterm labor. J Perinat Med. 2012 Nov;40(6):697-700. doi: 10.1515/jpm-2012-0136. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Adverse events Before and after use of electrical uterine pacemaker, assessed up to 120 minutes
Primary Uterine contraction frequency during labor as measured by external uterine tocodynamometric monitoring Change from 20, 40, and 80 minutes
Secondary FHR pattern as measured by the maternal-fetal monitor Change from 60 and 120 minutes
Secondary EMG monitoring as measured by LaborView Device Change from 60 and 120 minutes
Secondary EHG monitoring as measured by LaborView Device Change from 60 and 120 minutes
Secondary fECG monitoring as measured by LaborView Device Change from 60 and 120 minutes
Secondary Maternal pain medication administration Before and after use of electrical uterine pacemaker, assessed up to 120 minutes
Secondary Maternal heart rate Change from 60 and 120 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns